Navigation Links
Abaxis, Inc. to Present at the Stephens Fall Investment Conference
Date:11/7/2012

UNION CITY, Calif., Nov. 7, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, announced today that Don Wood, chief operations officer , will present at the Stephens Fall Investment Conference on Wednesday, November 14, 2012 at 8:45 a.m. ET. The conference will be held at The New York Palace Hotel in New York City.

About Abaxis
Abaxis develops, manufactures, markets and sells portable blood analysis systems for use in any veterinary or human patient-care setting to provide clinicians with rapid blood constituent measurements.  The system consists of a compact, 5.1 kilogram (11.2 pounds), portable analyzer and a series of single-use plastic discs, called reagent discs that contain all the chemicals required to perform a panel of up to 13 tests on veterinary patients and 14 tests on human patients.  The system can be operated with minimal training and performs multiple routine tests on whole blood, serum or plasma samples.  The system provides test results in less than 12 minutes with the precision and accuracy equivalent to a clinical laboratory analyzer.  The veterinary business also provides to the animal health and research market a line of hematology instruments for point-of-care complete blood counts (CBC), a specialty instrument to screen for and detect clotting disorders and to measure equine fibrinogen levels, a handheld instrument for the rapid assessment of certain critical care tests and rapid point-of-care tests for Heartworm infections, Parvovirus, Giardia and Lyme disease.  Abaxis, through its AVRL division, provides routine laboratory testing as well as specialty testing for veterinarians nationwide.Contact:

Clint Severson

Lytham Partners, LLCChief Executive Officer

Joe Dorame, Joe Diaz & Robert Blum ABAXIS, Inc.

602-889-9700 510-675-6500
'/>"/>

SOURCE Abaxis, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Abaxis, Inc. to Present at the Lazard Capital Markets 9th Annual Healthcare Conference
2. Abaxis, Inc. to Present at UBS Global Life Sciences Conference
3. Abaxis, Inc. to Present at CL Kings 10th Annual Best Ideas Conference 2012
4. Abaxis, Inc. to Present at the Morgan Stanley Global Healthcare Conference
5. Abaxis, Inc. to Present at the Canaccord Genuity 32nd Annual Growth Conference
6. Abaxis, Inc. to Present at the Jefferies 2012 Global Healthcare Conference
7. Omnicell To Present At Lazard Capital Markets 9th Annual Healthcare Conference
8. Optimer Pharmaceuticals to Present at November 2012 Investor Conferences
9. Isis Pharmaceuticals To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
10. PAREXEL International To Present At Lazard Capital Healthcare Conference And Jefferies Global Healthcare Conference
11. Halozyme Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2014)... , Kalifornien, 28. August 2014 /PRNewswire/ ... den Start der Patientenrekrutierung für eine ... Forschungsausnahmegenehmigung) zur Beurteilung der Sicherheit und ... von Aneurysmen („WEB") bekanntgegeben. Adam Arthur, MD, ... Department of Neurosurgery/Semmes-Murphey Clinic, und Hauptprüfarzt ...
(Date:8/28/2014)... N.Y. , Aug. 28, 2014 ... have entered a partnership to advance an experimental ... myeloma (SMM), an asymptomatic stage of myeloma. ... Program® (TAP), through which LLS forges collaborations with ... faster. OncoPep is developing a ...
(Date:8/28/2014)... Aug. 28, 2014  STAAR Surgical Company (NASDAQ: ... lenses and delivery systems for the eye, today announced that ... at the New York Palace Hotel on Wednesday, September 3 ... Caldwell , President and CEO will offer a general overview ... developments and be joined by Steve Brown , CFO, ...
Breaking Medicine Technology:Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 2Sequent Medical kündigt Start einer IDE-Studie für das WEB System zur Embolisation von Aneurysmen bekannt 3The Leukemia & Lymphoma Society Provides Equity Financing to OncoPep to Support Clinical Trial for Myeloma Vaccine 2STAAR Surgical To Present At The Baird 2014 Health Care Conference 2
... Pharma Inc. (Tokyo:4503, "Astellas") announced today that it is ... which will further reinforce the company,s commitment to corporate social ... "We are committed to adopting the Global Compact and ... day-to-day operations of our company and through Astellas, annual ...
... CITY, Nov. 10, 2011 Dynatronics Corporation (NASDAQ: ... ended September 30, 2011 during the morning of Monday, November ... call for investors later that day at 1:30 p.m. ET ... interested in participating should call (800) 926-5230 and use access ...
Cached Medicine Technology:Astellas Signs United Nations Global Compact 2Astellas Signs United Nations Global Compact 3
(Date:8/28/2014)... Twenty seven per cent of rheumatoid arthritis patients in ... known as anti-TNF therapies did not take them as ... Royal Infirmary were among those from 60 hospitals around ... the Arthritis Research UK Centre for Genetics and Genomics ... warned that failure to take the drugs correctly, known ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 AmeriPride Services, ... America, today announced the launch of its new Customer ... AmeriPride even easier and more convenient for customers. The ... online and better communicate with the company. , Features ... Access, download and pay bills ...
(Date:8/28/2014)... Clarity PSO , an operating division of ... Patient Safety Organization (PSO) for another three-year period under ... Quality (AHRQ). Clarity PSO will continue to provide valuable ... true intentions of the Patient Safety and Quality Improvement ... eager to continue our journey as a PSO and ...
(Date:8/28/2014)... (PRWEB) August 28, 2014 Genetic ... available throughout the world, with large reference laboratories ... Since laboratories differ with regard to the genetic ... costs, payers may struggle to find the most ... To help clients sort through these differences, Hayes, ...
(Date:8/28/2014)... veEDIS Clinical Systems, LLC has successfully ... in Lawrence Medical Center, located in Moulton, Alabama. ... patient care, veEDIS is a key ingredient in ... the authorized, confidential exchange of patient information at ... designed in accordance with clinical workflows and best ...
Breaking Medicine News(10 mins):Health News:Arthritis patients failing to take expensive medication, according to new research 2Health News:AmeriPride Services Launches New Customer Portal 2Health News:AmeriPride Services Launches New Customer Portal 3Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 2Health News:Clarity PSO Re-lists as a Patient Safety Organization and Continues to Advance Patient Safety 3Health News:Hayes, Inc. Unveils Laboratory Comparison Tables for GTE Clients 2Health News:veEDIS Clinical Systems “Delivers,” as the 2014 Edition CEHRT Emergency Department EHR System is Implemented at Lawrence Medical Center 2Health News:veEDIS Clinical Systems “Delivers,” as the 2014 Edition CEHRT Emergency Department EHR System is Implemented at Lawrence Medical Center 3
... U.S. HIV/AIDS Atlas , , WASHINGTON, June 22 ... Atlas ( http://www.MapHIV.org ) that highlights ... United States. The Atlas makes information on HIV/AIDS prevalence ... painting a comprehensive picture of the varying intensity of the ...
... Hoag ... of Cardiology) as its executive medical director of the Hoag Heart and Vascular Institute (HHVI). ... Newport Beach, Calif. ... Tancredi, M.D., F.A.C.C. (Fellow of the American College of Cardiology) as its executive medical director ...
... Time for Fitness! , , LOS ANGELES, June 22 ... the park or along the beach. Now a brand new product ... equipment on wheels, but with a unique design to allow your ... new concept of fitness, will be introduced to California starting from ...
... study finds, , MONDAY, June 22 (HealthDay News) -- ... blood pressure, but new research finds those extra pounds can ... especially if she experiences early menopause. , Published in the ... found that women with a body-mass index (BMI) greater than ...
... CRO expertise in $1 billion market for cancer support ... , WATERTOWN, Mass., June 22 Biomodels LLC, ... today announced that its customized research program allowed ActoGeniX ... Food and Drug Administration (FDA) approval for Phase 1b ...
... LLC, the rising star of the Sports Nutrition Industry, ... each of Vitamin Shoppe,s 400+ locations nationwide. , ... of our entire line of products," MUSCLEPHARM president Brad ... in nearly every neighborhood across the nation! Vitamin Shoppe ...
Cached Medicine News:Health News:MapHIV.org Shows California's San Francisco County Seriously Impacted by HIV 2Health News:MapHIV.org Shows California's San Francisco County Seriously Impacted by HIV 3Health News:Nationally Acclaimed Cardiologist Joins Hoag Heart and Vascular Institute as Executive Medical Director 2Health News:Pumgo Fitness Scooter Will Highlight Venice Beach This Summer 2Health News:Obesity Greatly Raises Endometrial Cancer Risk 2Health News:Obesity Greatly Raises Endometrial Cancer Risk 3Health News:Biomodels' Oral Mucositis Expertise Speeds FDA Approval for ActoGeniX's Phase 1b Trial of AGO13 in Cancer Patients 2Health News:MUSCLEPHARM Products Hit Vitamin Shoppe Shelves With a Bang! 2
... The design of the Hi-Top ... to be held back in ... shoe counter. The front is ... and compression on the toes. ...
... semi-rigid post op shoe is ideal for ... breathable upper will keep your patient both ... closure provides even tension and compression. The ... support for your patient. The black TPR ...
Comfortably positions the affected foot at 90 to provide continuous and effective stretching of the plantar fascia and Achilles Tendon...
... Bird and Cronin, Inc. ... of Patient Footwear, Orthopedic ... Care Products. Our products ... quality and available in ...
Medicine Products: